Skyeline Management Ltd, 10% Owner, Director at Royalty Pharma plc (RPRX), sold 560,532 shares at $44.11 ($24.7M) on 2022-12-01, disclosed to the SEC on 2022-12-05.
Open-market sale of $24.7M RPRX by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.11 | 165,000 | $7.3M | 29.5% |
| 2 | $43.98 | 197,766 | $8.7M | 35.3% |
| 3 | $43.98 | 197,766 | $8.7M | 35.3% |
| Total | $44.02 avg | 560,532 | $24.7M | 100% |